Details of Disease

General Information of Disease (ID: DISA8CF0)

• Disease Name: Diabetic gastroparesis
• Disease Class: DA41: Gastroduodenal motor/secretory disorder
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISA8CF0: Diabetic gastroparesis
• ICD Code:
  ICD-11: ICD-11: DA41.00
  Expand ICD-9: 250536.3

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 7 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ETX-101	DM9WECZ	Phase 3	NA	[1]
EVK-001	DMG4UJ6	Phase 3	NA	[2]
RM-131	DMD709J	Phase 3	NA	[1]
Camicinal	DMAKSMX	Phase 2	Small molecular drug	[1]
SPD-557	DMJH2AC	Phase 2	NA	[3]
TAK-906	DMBQD9H	Phase 2	Small molecular drug	[4]
TZP-102	DMBB9UK	Phase 2	NA	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of Evoke Pharma.
• [3] ClinicalTrials.gov (NCT01370863) An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients. U.S. National Institutes of Health.
• [4] ClinicalTrials.gov (NCT03544229) A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis. U.S. National Institutes of Health.
• [5] ClinicalTrials.gov (NCT01664637) Diabetic Gastroparesis Efficacy/Safety Study of TZP-102. U.S. National Institutes of Health.